Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin

Coagulation activation and venous thromboembolism (VTE) are hallmarks of cancer; however, there is an unmet need of improved biomarkers for individualized anticoagulant treatment. The present sub-study of the RASTEN trial was designed to explore the role of coagulation biomarkers in predicting VTE r...

Descripción completa

Detalles Bibliográficos
Autores principales: Gezelius, E., Flou Kristensen, A., Bendahl, P. O., Hisada, Y., Risom Kristensen, S., Ek, L., Bergman, B., Wallberg, M., Falkmer, U., Mackman, N., Pedersen, S., Belting, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226210/
https://www.ncbi.nlm.nih.gov/pubmed/30412630
http://dx.doi.org/10.1371/journal.pone.0207387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226210/
https://www.ncbi.nlm.nih.gov/pubmed/30412630
http://dx.doi.org/10.1371/journal.pone.0207387

Ejemplares similares